BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38555763)

  • 1. Toxin-triggered liposomes for the controlled release of antibiotics to treat infections associated with the gram-negative bacterium, Aggregatibacter actinomycetemcomitans.
    Li Z; Baidoun R; Brown AC
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113870. PubMed ID: 38555763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxin-Triggered Liposomes for the Controlled Release of Antibiotics to Treat Infections Associated with Gram-Negative Bacteria.
    Li Z; Baidoun R; Brown AC
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.
    Brown AC; Boesze-Battaglia K; Du Y; Stefano FP; Kieba IR; Epand RF; Kakalis L; Yeagle PL; Epand RM; Lally ET
    Cell Microbiol; 2012 Jun; 14(6):869-81. PubMed ID: 22309134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.
    Brown AC; Boesze-Battaglia K; Balashova NV; Mas Gómez N; Speicher K; Tang HY; Duszyk ME; Lally ET
    PLoS One; 2018; 13(10):e0205871. PubMed ID: 30335797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
    Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
    Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
    Krueger E; Brown AC
    Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
    Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
    Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
    Crosby JA; Kachlany SC
    Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.
    Brown AC; Balashova NV; Epand RM; Epand RF; Bragin A; Kachlany SC; Walters MJ; Du Y; Boesze-Battaglia K; Lally ET
    J Biol Chem; 2013 Aug; 288(32):23607-21. PubMed ID: 23792963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
    Chang EH; Brown AC
    J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.
    Balashova N; Giannakakis A; Brown AC; Koufos E; Benz R; Arakawa T; Tang HY; Lally ET
    Gene; 2018 Sep; 672():106-114. PubMed ID: 29879499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.
    Balashova NV; Shah C; Patel JK; Megalla S; Kachlany SC
    Gene; 2009 Aug; 443(1-2):42-7. PubMed ID: 19450669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranberry Proanthocyanidins Neutralize the Effects of
    Ben Lagha A; Howell A; Grenier D
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
    [No Abstract]   [Full Text] [Related]  

  • 15. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
    Kachlany SC
    J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Vega BA; Belinka BA; Kachlany SC
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
    Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
    J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.
    Balashova NV; Park DH; Patel JK; Figurski DH; Kachlany SC
    Infect Immun; 2007 Sep; 75(9):4490-7. PubMed ID: 17635874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Size and Toxin Distribution in
    Nice JB; Collins SM; Agro SMJ; Sinani A; Moros SD; Pasch LM; Brown AC
    Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535804
    [No Abstract]   [Full Text] [Related]  

  • 20. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin.
    Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A
    Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.